Free Newsletter
Roche wins round in battle for Ventana
Hostile takeovers are no fun to be part of but they're exciting to watch. Roche won the latest round in its bid for Ventana Medical Systems: An Arizona court granted an injunction against Ventana's use of anti-takeover statutes to block Roche's bid for the company.
You'll recall that Roche made a tender offer for Ventana back in June at a price of $75 per share; the previous trading day, Ventana stock had closed at $51.95. In July, the Ventana board told shareholders not to cash in their shares because the Roche offer was "inadequate." Just yesterday, Roche extended its offer through September 20; only some 13,500 shareholders had tendered their stock--and Ventana has 35.6 million shares outstanding. Ventana shares are now trading at $82.51.
- see the release
- check out the AP report
Related Articles:
Roche note opens door to a higher Ventana bid. Report
Ventana spurns Roche's $3B hostile takeover bid. Report
Ventana shares soar on hostile $3B bid. Report
Roche shakes up R&D, eyes new buyouts. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: